Janet Mcgill MD, MA, FACE, FACP

Dr. Janet McGill completed her internship and residency and was chief resident at William Beaumont Hospital in Royal Oak, Michigan. After her fellowship in Endocrinology at Washington University, she joined the faculty in 1987. She has been an active clinical researcher in diabetes for over 25 years and continues to test new therapies for diabetes and novel approaches to type 1 and type 2 diabetes. Currently, Dr. McGill is the principal investigator (PI) or sub-investigator on more than 10 clinical trials investigating new treatments for diabetes and its complications.

She has served on steering and safety committees for multi-centered clinical trials, including RENAAL, TREAT, FOCAL, KEEP, and the SUN studies in diabetic nephropathy, and currently serves on planning committees and data safety monitoring boards for several ongoing national and international clinical trials. She is a member of the board of directors for the American Association of Clinical Endocrinologists and the AACE Diabetes Scientific Committee, which recently published updated guidelines for the care of persons with type 2 diabetes. Dr. McGill directs the Fellowship in Endocrinology, Diabetes, and Metabolism and has a busy practice at the Center for Advanced Medicine, treating patients with diabetes, thyroid disease, and other endocrine problems.